147 related articles for article (PubMed ID: 23721635)
1. Molecular genetic classification of difficult melanocytic tumors.
Metzler G; Eigentler TK; Held L; Kind P; Hantschke M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():11-8. PubMed ID: 23721635
[No Abstract] [Full Text] [Related]
2. Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.
Wiesner T; Fried I; Cerroni L; Kutzner H
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():19-24. PubMed ID: 23721637
[No Abstract] [Full Text] [Related]
3. Mutation analysis in malignant melanoma.
Gaiser MR; Stadler R; Schirmacher P; Dietel M; Enk A
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():2-10. PubMed ID: 23721634
[No Abstract] [Full Text] [Related]
4. Molecular pathology diagnostics in cutaneous mesenchymal tumors.
Kutzner H; Requena L; Palmedo G; Mentzel T
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():36-49. PubMed ID: 23721641
[No Abstract] [Full Text] [Related]
5. Molecular diagnostics in cutaneous lymphomas.
Möbs M; Cerroni L; Flaig MJ; Lenze D; Hummel M; Assaf C
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():25-35. PubMed ID: 23721639
[No Abstract] [Full Text] [Related]
6. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
de la Fouchardière A; Vergier B
Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
[No Abstract] [Full Text] [Related]
7. [Molecular diagnosis of melanocytic tumors].
Bauer J
Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
[TBL] [Abstract][Full Text] [Related]
8. Neurofibroma-like spindle cell melanoma: CD34 fingerprint and CGH for diagnosis.
Yeh I; Vemula SS; Mirza SA; McCalmont TH
Am J Dermatopathol; 2012 Aug; 34(6):668-70. PubMed ID: 22456515
[TBL] [Abstract][Full Text] [Related]
9. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnostics in infectious skin diseases.
Kempf W; Flaig MJ; Kutzner H
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():50-8. PubMed ID: 23721643
[No Abstract] [Full Text] [Related]
11. Molecular markers in melanoma.
Kashani-Sabet M
Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
[TBL] [Abstract][Full Text] [Related]
12. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
13. Microarray comparative genomic hybridization detection of copy number changes in desmoplastic melanoma and malignant peripheral nerve sheath tumor.
Pryor JG; Brown-Kipphut BA; Iqbal A; Scott GA
Am J Dermatopathol; 2011 Dec; 33(8):780-5. PubMed ID: 21785329
[TBL] [Abstract][Full Text] [Related]
14. Molecular techniques for predicting behaviour in melanocytic neoplasms.
Lee CY; Gerami P
Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
[TBL] [Abstract][Full Text] [Related]
15. Mutational profiling in melanocytic tumors: multiple somatic mutations and clinical implications.
Richetta AG; Silvestri V; Giancristoforo S; Rizzolo P; D'Epiro S; Graziano V; Mattozzi C; Navazio AS; Falchetti M; Calvieri S; Ottini L
Oncology; 2014; 86(2):104-8. PubMed ID: 24457427
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
Gerami P; Geraminegad P
G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
[TBL] [Abstract][Full Text] [Related]
17. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing.
Lang UE; Yeh I; McCalmont TH
Clin Lab Med; 2017 Sep; 37(3):473-484. PubMed ID: 28802496
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic markers of prognosis in melanoma.
Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
Methods Mol Biol; 2014; 1102():481-99. PubMed ID: 24258994
[TBL] [Abstract][Full Text] [Related]
20. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
High WA
Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]